Cardiac digital image loops and multimedia reports over the internet using DICOM.

The authors define an open, scaleable telemedicine architecture to reduce the time of reports delivery and consultation; increasing their simplicity via introducing common image presentation, storage and telecommunication formats and methods for telecardiology. They've developed a software application to implement it introducing the most appropriate digital imaging methods and formats using the latest available technology.

[Treatment of acute ST-elevation myocardial infarction with primary percutaneous coronary intervention].

Introduction: Treatment of acute myocardial infarction has changed significantly in recent years. Since January 1st, 2003 primary coronary intervention has been organized in Budapest. The authors show the results during the implementation of this method in the first 6 months with emphasizing its importance.

[Primary percutaneous coronary angioplasty in acute myocardial infarction. Measures of quality control for the work of the hemodynamics laboratory].

The results of primary percutane coronary angioplasty in acute myocardial infarction were studied and compared to international standards. We tried to develop new quality indicators for objective comparison. Seventy nine patients with acute myocardial infarction were included in the study, 47 of them from the pre-stent, and 32 from the stent era.

[Use of coronary vessel prosthesis. Complex coronary angioplasty under general anesthesia].

In 1995 we attempted to treat with PTCA 437 ischemic patients. We stended 29 patients (6.6%) with 34 stents.

Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.

These are the preliminary data of an open multicenter trial of antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11) or isradipine (7.

Comparative examination of Adalat and Cordaflex in anti-ischaemic therapy.

The efficacy of Cordaflex (EGIS) and Adalat (Bayer), both containing 10 mg nifedipine, has been examined in ischaemic cardiopathic patients. The fifteen ischaemic cardiopathic patients were treated with identical doses of Cordaflex and Adalat, simultaneously with unchanged nitrate and beta-blocker therapy. The patients received 30-80-mg identical nifedipine doses daily for 1 week each.

Antihypertensive effect of bopindolol: a multi-centre study.

The objective of the study was to investigate the efficacy of different dose levels of bopindolol monotherapy in hypertension. This potent nonselective beta-adrenergic receptor blocker has intrinsic sympathomimetic activity and long duration of action. Forty-four patients with essential hypertension of mild (n = 40) or moderate (n = 4) severity (90 less than DBP less than or equal to 115 mmHg at the end of the placebo period) entered and completed the single-blind, placebo-controlled trial.

Clinical examination of heparin-Ca in myocardial infarction patients.

The clinical effect of subcutaneous heparin-Ca of delayed action (Heparin Calcium inj. 25,000 IU/ml, Chemical Works of Gedeon Richter) has been examined in 26 acute and 6 imminent myocardial infarction patients. The therapy was started with 10,000 IU intravenous heparin dose.

Captopril (Tensiomin) in the treatment of chronic heart failure of ischaemic heart disease patients.

The authors used Captopril (Tensiomin, Egis Pharmaceuticals, Budapest) therapy in seven patients suffering from chronic heart failure of ischaemic etiology. As controls, seven patients with dilated cardiomyopathy were involved in the study. All 14 patients received digitalis, diuretic, and isosorbide dinitrate therapy but their condition aggrevated in spite of the therapy.

Baropacing of the carotid sinus nerve for treatment of "Intractable" hypertension.

The authors applied with success the electrical stimulation of the carotid sinus nerve in the case of a hypertension of long duration which was refractory to antihypertensive drugs. For the stimulation of the carotid sinus nerve a Medtronic "Barostat" device was implanted. Since the implantation- or rather since its usage- the blood pressure of the patient decreased to a great extent, and her complaints disappeared.